Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
anemia
anemia, hemolytic
blood dyscrasias, neurologic findings with
CAT scan
CAT scan, abnormal
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
Clinical Pathologic Conference(C.P.C.)
congenital heart disease
congenital heart disease, CNS complications with
enzyme, defect
falx cerebri
gadolinium
hematopoietic tissue, extramedullary
hemoglobin abnormality, neurologic complications of
leg weakness, bilateral
low back pain
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, spine
myelitis, transverse
myelodysplasia
myelofibrosis
myelopathy
neuropathology
Paget's disease
Paget's disease, spinal cord problem in
pain
pain, back
papilledema
paraparesis
paraparesis, spastic
paraplegia
paraplegia, acute
polycythemia, primary
pyruvate-kinase deficiency anemia
radiation therapy, CNS treatment and complications with
radiculitis
radiculopathy
seizure
sickle cell disease
spinal cord, compression of
spinal cord, neoplasm
spinal cord, neoplasm, extramedullary
thalassemia
transient ischemic attack
transposition of the great vessels
treatment of neurologic disorder
Showing articles 900 to 950 of 1295 << Previous Next >>

Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Evaluation of Surgery for Parkinson's Disease, A Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 53:1910-1921, Hallett,M.,et al, 1999

Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999

Use of Placebo Surgery in Controlled Trials of a Cellular-Based Therapy for Parkinson's Disease
NEJM 341:988-992, Freeman,T.B.,et al, 1999

Intra-Arterial Cerebral Thrombolysis for Acutre Ischemic Stroke in a Community Hospital
AJNR 20:1682-1687,1580, Edwards,M.T.,et al, 1999

Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999

Acute Disseminated Encephalomyelitis:MR Imaging Features
AJR 173:1101-1107, Singh,S.,et al, 1999

The Stiff-Person Syndrome:An Autoimmune Disorder Affecting Neurotransmission of y-Aminobutyric Acid
Ann Int Med 131:522-530, Levy,L.M.,et al, 1999

Long-Term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
Arch Neurol 56:179-187, Hauser,R.A.,et al, 1999

CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Acute Vertebrobasilar Occlusion:Treatment with High-Dose Intraarterial Urokinase
AJR 172:709-712, Hoffman,A.I.,et al, 1999

Application of a Rheolytic Thrombectomy Device in the Treatment of Dural Sinus Thrombosis:A New Technique
AJNR 20:568-570, Dowd,C.F.,et al, 1999

Evidence of Anaphylaxy after Alteplase Infusion
Stroke 30:1142-1143, Rudolf,J.,et al, 1999

Superselective Intraarterial Fibrinolysis in Central Retinal Artery Occlusion
AJNR 20:565-567, Padolecchia,R.,et al, 1999

Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999

Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999

Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999

Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999

Angiitis of the Central Nervous System After Allogeneic Bone Marrow Transplantation?
Stroke 30:1651-1656, Padovan,C.S.,et al, 1999

Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999

Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999

"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999

Intra-Arterial rtPA Treatment of Stroke Assessed by Diffusion- and Perfusion-Weighted MRI
Stroke 30:678-680, Lansberg,M.G.,et al, 1999

Factors Associated with Delayed Admission to Hospital and In-Hospital Delays in Acute Stroke and TIA,A Prospective,Multicenter Study
Stroke 30:40-48, Wester,P.,et al, 1999

Elevated Tissue Plasminogen Activator Antigen and Stroke Risk,The Stroke Prevention in Young Women Study
Stroke 30:7-11, Macko,R.F.,et al, 1999

Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999

Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Opsoclonus as a Dominant Sign in Primary Sjogrens Syndrome
Neuro-Opthlhal 22:135-138, Lubec,D.,et al, 1999

Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998

Thrombolysis with Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke,Determination of Etiological,Topographic,and Radiological Outcome Factors
Stroke 29:2529-2540, Trouillas,P.,et al, 1998

Alteplase Not Yet Proven for Acute Ischaemic Stroke
Lancet 352:1238-1239,1245, Bath,P., 1998

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

Dystonia and Chorea in Acquired Systemic Disorders
JNNP 65:436-445, Janavs,J.L.&Aminoff,M.J., 1998

Concurrent Medical Disease in Work-Relatede Carpal Tunnel Syndrome
Arch Int Med 158:1506-1512, 14961998., Atcheson,S.G.,et al, 1998

Brown -Sequard at a Theme Park
Lancet 352:1902, Bateman,D.E.&Pople,I, 1998

Factors Determining the Therapeutic Window for Stroke
Neurol 50:599-603, Zivin,J.A., 1998

Selective Intra-arterial Fibrinolysis of Acute Central Retinal Artery Occlusion
Stroke 29:2076-2079, Weber,J.,et al, 1998

Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998

Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998

PROACT:Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute MCA Stroke
Stroke 29:4-11, delZoppo,G.J.,et al, 1998

tPA-Associated Reperfusion After Acute Stroke Demonstrated by SPECT
Stroke 29:429-432, Grotta,G.J.&Alexandrov,A.V., 1998

I. V. t-PA for Acute Ischemic Stroke, Feasibility, Safety & Efficacy in the First Year of Clinical Practice
Stroke 29:18-22, Chiu,D.,et al, 1998

Thrombolytic Therapy in Acute Stroke
Arch Neurol 55:155-157, Horowitz,S.H., 1998

Long-Term Stabilization After Bone Marrow Transplantation in Juvenile Metachromatic Leukodystrophy
Arch Neurol 55:98-99, Kidd,D.,et al, 1998



Showing articles 900 to 950 of 1295 << Previous Next >>